Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 301

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 2
Chunk 301
---
 the aggregate fair values of the Company’s Backstop Put Option Liability, Fixed Maturity
Consideration, the 2023/2024 Convertible Notes, SPA Warrant, and Ayrton Note Purchase Option for which fair values are determined using Level
3 inputs:

 Schedule of Fair Value Backstop Forward Purchase Agreement Asset

    Level 3 Rollforward (in thousands) 
    Backstop Put Option Liability  
    Fixed Maturity Consideration  
    2023/2024 Convertible Note  
    SPA Warrant  
    Ayrton Note Purchase Option 
  
    Balances as of January 1, 2023 
    $-  
    $-  
    $-  
    $-  
    $- 
  
    Initial fair value measurement 
     (12,414) 
     (3,166) 
     (5,628) 
     (1,932) 
     (269)
  
    Changes in fair value 
     (46,109) 
     (957) 
     10  
     1,168  
     269 
  
    Balance as of December 31, 2023 
     (58,523) 
     (4,123) 
     (5,618) 
     (764) 
     - 
  
    Balance 
     (58,523) 
     (4,123) 
     (5,618) 
     (764) 
     - 

    Effect of Note Exchange 
     -  
     -  
     (504) 
     (430) 
     - 
  
    Additional 2024 Notes issued 
     -  
     -  
     (3,680) 
     -  
     - 
  
    Changes in fair value 
     (533) 
     (1,450) 
     (1,573) 
     105  
     - 
  
    Balance as of December 31, 2024 
     (59,056) 
     (5,573) 
     (11,375) 
     (1,089) 
     - 

    Balance 
     (59,056) 
     (5,573) 
     (11,375) 
     (1